Form 4 holding
SVP, Chief Legal Officer
Mersana Therapeutics, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 0
- Estimated value
- $135,500
- Report date
- 06 Jan 2026
- Price
- $2.71
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount